Skip to content

Sun Pharma hits 52- week high on USFDA all-clear to Ankleshwar unit

The USFDA classified the unit as No Action Indicated, paving the way for manufacturing and export from the plant, a CNBC Awaaz report said

Read More

​ The USFDA classified the unit as No Action Indicated, paving the way for manufacturing and export from the plant, a CNBC Awaaz report said The USFDA classified the unit as No Action Indicated, paving the way for manufacturing and export from the plant, a CNBC Awaaz report said  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish